"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...

A U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...

In a significant leap forward, India's drug authority, CDSCO, is poised for a transformative upgrade. The government is embarking on an ini...

A tragic repeat of the 1937 Elixir Sulfanilamide disaster, where diethylene glycol (DEG) killed 107 people, has occurred in India. In Augus...

Almost always and without an exception, the results of clinical trials of drugs are published in the most prestigious medical journals, whi...

The Directorate General of Foreign Trade (DGFT) has made it mandatory for all cough syrup exporters to have their product tested and certif...

News that 48 common drugs manufactured in India failed to meet quality standards comes as little surprise. The absence of a robust drug reg...

In 2019, Indian pharma companies received 19 warning letters. Nearly half were from the Office of Manufacturing Quality, US Food and Drug A...

Shareholder activism, new regulations, whistleblowers and social media have ensured that companies improve governance

The price regulator will ensure that all medicines are regulated and are available at affordable rates to the public.

Most of the pharma stocks barring a few, are probably at a range where there is not that much left on the table, says Tandon.

Zenotech Laboratories has termed Sun Pharma's open offer worth Rs 20.23 crore to acquire a little over 28 per cent stake in the company as ...

The Andhra Pradesh high court on Saturday vacated stay orders it issued last month on the merger of two firms that would create world’s fou...

Puducherry-based drugmaker GuruFcure has come under the scanner for allegedly submitting fabricated data.

The decision to make compensation mandatory in such cases comes four weeks after the Supreme Court chided the government for its sloppy reg...

Sun Pharma said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it.

India’s largest drugmaker by market capitalisation Sun Pharma whose US arm recalled one of the products sold in the world’s largest drug ma...